Stock APLLTD ALEMBIC PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Alembic Pharmaceuticals Limited

Equities

APLLTD

INE901L01018

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 06:22:06 2024-04-25 am EDT 		5-day change 1st Jan Change
997.5 INR +4.12% Intraday chart for Alembic Pharmaceuticals Limited +7.14% +31.35%
Apr. 08 Alembic Pharmaceuticals Limited Received 3 Assessment Orders from the Office of Assistant Commissioner (ST), Andhra Pradesh CI
Apr. 02 Alembic Pharmaceuticals Appoints Manish Kejriwal as Independent Director CI

Business Summary

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

Number of employees: 14,593

Sales per Business

INR in Million2022Weight2023Weight Delta
Formulations
79.4 %
43,673 82.3 % 44,871 79.4 % +2.74%
Active Pharmaceutical Ingredients
20.6 %
9,385 17.7 % 11,655 20.6 % +24.19%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
53,058 100.0 % 56,526 100.0 % +6.54%

Managers

Managers TitleAgeSince
Chirayu Ramanbhai Amin CEO
 Chief Executive Officer 76 83-04-30
Raj Kumar Shriram Baheti DFI
 Director of Finance/CFO 64 03-01-17
Manisha Saraf CMP
 Compliance Officer - 23-03-31
Pranav Chirayu Amin BRD
 Director/Board Member 48 06-12-31
Shaunak Chirayu Amin BRD
 Director/Board Member 46 11-03-30
Ajay Kumar Desai PRN
 Corporate Officer/Principal - 08-08-31
Mitanshu Shah PRN
 Corporate Officer/Principal - 06-04-30

Members of the board

Members of the board TitleAgeSince
Chirayu Ramanbhai Amin CEO
 Chief Executive Officer 76 83-04-30
Raj Kumar Shriram Baheti DFI
 Director of Finance/CFO 64 03-01-17
Archana Niranjan Hingorani BRD
 Director/Board Member 56 15-02-03
Shaunak Chirayu Amin BRD
 Director/Board Member 46 11-03-30
Ashok Kumar Barat BRD
 Director/Board Member 66 22-02-09
Pranav Chirayu Amin BRD
 Director/Board Member 48 06-12-31
Jai Shishir Diwanji BRD
 Director/Board Member 51 23-05-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 196,563,124 57,547,288 ( 29.28 %) 0 29.28 %

Shareholders

NameEquities%Valuation
Nirayu Pvt Ltd.
35.63 %
70,035,435 35.63 % 825 M ₹
ALEMBIC LIMITED
28.54 %
56,097,544 28.54 % 661 M ₹
Life Insurance Corporation of India (Investment Portfolio)
4.326 %
8,502,500 4.326 % 100 M ₹
DSP Asset Managers Pvt. Ltd.
3.925 %
7,714,255 3.925 % 91 M ₹
Chirayu Ramanbhai Amin
2.133 %
4,192,529 2.133 % 49 M ₹
Kotak Mahindra Asset Management Co. Ltd.
1.764 %
3,468,355 1.764 % 41 M ₹
Malika Chirayu Amin
1.529 %
3,005,730 1.529 % 35 M ₹
Government of India
0.7014 %
1,378,701 0.7014 % 16 M ₹
Union Asset Management Co. Pvt Ltd.
0.5478 %
1,076,751 0.5478 % 13 M ₹
Pranav Chirayu Amin
0.5137 %
1,009,800 0.5137 % 12 M ₹

Company contact information

Alembic Pharmaceuticals Ltd.

Alembic Road

390003, Vadodara

+91 26 5663 7000

http://alembicpharmaceuticals.com
address Alembic Pharmaceuticals Limited(APLLTD)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Alembic Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
958 INR
Average target price
937.7 INR
Spread / Average Target
-2.12%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ALEMBIC PHARMACEUTICALS LIMITED Stock Alembic Pharmaceuticals Limited
+28.25% 2.26B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 660B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.87% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+7.09% 219B
ROCHE HOLDING AG Stock Roche Holding AG
-9.12% 196B
NOVARTIS AG Stock Novartis AG
+5.01% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. APLLTD Stock
  4. Company Alembic Pharmaceuticals Limited